Kaken Pharmaceutical Co., Ltd.
Notice of Executive Personnel Changes
Kaken Pharmaceutical Co., Ltd. announced planned changes to its directors and auditors in late June 2026, with the appointment of a new executive officer effective July 1, 2026.
Key Figures
- Scheduled Director Change Date: Late June 2026
- Scheduled Auditor Change Date: Late June 2026
- Scheduled Executive Officer Change Date: Effective July 1, 2026
AI要約
Overview of Executive Changes
At the board of directors meeting held on March 27, 2026, Kaken Pharmaceutical Co., Ltd. resolved changes to its directors, auditors, and executive officers. All directors are scheduled for reappointment at the 106th Annual General Meeting of Shareholders to be held in late June 2026, with no change to the representative. Regarding auditors, one new outside auditor will be appointed, one outside auditor will retire, and one full-time auditor will be reappointed. One new executive officer is scheduled to assume office effective July 1, 2026.
Upcoming Schedule and Organizational Structure
Election of directors and auditors will be decided at the Annual General Meeting of Shareholders scheduled for June 2026. Under the new structure, President Hiroyuki Horiuchi will lead alongside managing directors, directors, outside directors, auditors, outside auditors, and executive officers fulfilling their respective roles. This will establish a system aimed at ensuring management continuity and strengthening supervisory functions.
